NPR: House Republicans Aim To Eliminate Tax Credits For Orphan Drugs
For more than three decades, pharmaceutical companies have claimed a 50 percent tax credit for the cost of clinical trials of drugs for rare diseases. The credit is now in jeopardy.
Tax credits for “orphan drugs” could be eliminated under current GOP plan, which will mean fewer drugs developed for rare diseases.
